Steris (Steris) Interest Expense : $-139 Mil (TTM As of Dec. 2023)

View and export this data going back to 1992. Start your Free Trial

What is Steris Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Steris's interest expense for the three months ended in Dec. 2023 was $ -39 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was $-139 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Steris's Operating Income for the three months ended in Dec. 2023 was $ 216 Mil. Steris's Interest Expense for the three months ended in Dec. 2023 was $ -39 Mil. Steris's Interest Coverage for the quarter that ended in Dec. 2023 was 5.55. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Steris Interest Expense Historical Data

The historical data trend for Steris's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Steris Interest Expense Chart

Steris Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Interest Expense

Get a 7-Day Free Trial

-45.02

-40.28

-37.18

-89.59

-110.84

Steris Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Interest Expense	Get a 7-Day Free Trial															-30.47	-30.28	-32.36	-36.94	-38.95

Steris Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-139 Mil.

Steris (NYSE:STE) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Steris's Interest Expense for the three months ended in Dec. 2023 was $-39 Mil. Its Operating Income for the three months ended in Dec. 2023 was $216 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2023 was $3,394 Mil.

Steris's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2023 )	/	Interest Expense (Q: Dec. 2023 )
	=	-1	*	216.162	/	-38.947
	=	5.55

The higher the ratio, the stronger the company's financial strength is.

Steris (Steris) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Steris PLC (NYSE:STE) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

S1TE34:Brazil

Address

5960 Heisley Road, Mentor, OH, USA, 44060

Website

https://www.steris-ir.com

Steris is an Ireland-domiciled medical device company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Additionally, Steris sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its 2015 inversion to Ireland, the firm continues to derive roughly 70% of revenue from its U.S. operations, 10% from the United Kingdom, and the remaining 20% from other international regions.

Executives

Richard C Breeden	director	100 SOUTH WACKER, SUITE 1800, CHICAGO IL 60606
Cynthia L Feldmann	director	17 WINTHROP ROAD, WAYLAND MA 01778
Jacqueline B Kosecoff	director	5960 HEISLEY ROAD, MENTOR OH 44060
Mohsen Sohi	director	C/O STERIS CORPORATION, 5960 HEISLEY ROAD, MENTOR OH 44060
Esther M. Alegria	director	2642 MICHELLE DRIVE, SUITE 200, TUSTIN CA 92780
Cary L Majors	officer: VP, N America Com Operations	5960 HEISLEY ROAD, MENTOR OH 44060
John Adam Zangerle	director, officer: Sr. VP, Gen Counsel, and Sec.	5960 HEISLEY ROAD, MENTOR OH 44060
Michael J Tokich	director, officer: Sr. Vice Pres., CFO	C/O STERIS CORP, 5960 HEISLEY RD, MENTOR OH 44060
Karen L Burton	officer: VP, Controller & CAO	5960 HEISLEY ROAD, MENTOR OH 44060
Renato Tamaro	officer: V.P. & Corporate Treasurer	5960 HEISLEY ROAD, MENTOR OH 44060
Andrew Xilas	officer: SVP and GM, Dental	5960 HEISLEY ROAD, MENTOR OH 44060
Paul Edward Martin	director	C/O UNISYS CORPORATION, 801 LAKEVIEW DRIVE, SUITE 100, BLUE BELL PA 19422
Julia Madsen	officer: Senior VP, Life Sciences	5960 HEISLEY ROAD, MENTOR OH 44060
David B Lewis	director
Rosebrough Walter M Jr	officer: President & CEO	5960 HEISLEY ROAD, MENTOR OH 44060